Cargando…
Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides
Natural bioactive peptides are suitable candidates for preventing the development of Type 2 diabetes (T2D), by reducing the various risk factors. The aim of this study was to concentrate glucoregulatory and anti-inflammatory peptides, from salmon by-products, by electrodialysis with ultrafiltration...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305187/ https://www.ncbi.nlm.nih.gov/pubmed/34357178 http://dx.doi.org/10.3390/membranes11070528 |
_version_ | 1783727514223378432 |
---|---|
author | Henaux, Loïc Pereira, Karina Danielle Thibodeau, Jacinthe Pilon, Geneviève Gill, Tom Marette, André Bazinet, Laurent |
author_facet | Henaux, Loïc Pereira, Karina Danielle Thibodeau, Jacinthe Pilon, Geneviève Gill, Tom Marette, André Bazinet, Laurent |
author_sort | Henaux, Loïc |
collection | PubMed |
description | Natural bioactive peptides are suitable candidates for preventing the development of Type 2 diabetes (T2D), by reducing the various risk factors. The aim of this study was to concentrate glucoregulatory and anti-inflammatory peptides, from salmon by-products, by electrodialysis with ultrafiltration membrane (EDUF), and to identify peptides responsible for these bioactivities. Two EDUF configurations (1 and 2) were used to concentrate anionic and cationic peptides, respectively. After EDUF separation, two fractions demonstrated interesting properties: the initial fraction of the EDUF configuration 1 and the final fraction of the EDUF configuration 2 both showed biological activities to (1) increase glucose uptake in L6 muscle cells in insulin condition at 1 ng/mL (by 12% and 21%, respectively), (2) decrease hepatic glucose production in hepatic cells at 1 ng/mL in basal (17% and 16%, respectively), and insulin (25% and 34%, respectively) conditions, and (3) decrease LPS-induced inflammation in macrophages at 1 g/mL (45% and 30%, respectively). More impressive, the initial fraction of the EDUF configuration 1 (45% reduction) showed the same effect as the phenformin at 10 μM (40%), a drug used to treat T2D. Thirteen peptides were identified, chemically synthesized, and tested in-vitro for these three bioactivities. Thus, four new bioactive peptides were identified: IPVE increased glucose uptake by muscle cells, IVDI and IEGTL decreased hepatic glucose production (HGP) of insulin, whereas VAPEEHPTL decreased HGP under both basal condition and in the presence of insulin. To the best of our knowledge, this is the first time that (1) bioactive peptide fractions generated after separation by EDUF were demonstrated to be bioactive on three different criteria; all involved in the T2D, and (2) potential sequences involved in the improvement of glucose uptake and/or in the regulation of HGP were identified from a salmon protein hydrolysate. |
format | Online Article Text |
id | pubmed-8305187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83051872021-07-25 Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides Henaux, Loïc Pereira, Karina Danielle Thibodeau, Jacinthe Pilon, Geneviève Gill, Tom Marette, André Bazinet, Laurent Membranes (Basel) Article Natural bioactive peptides are suitable candidates for preventing the development of Type 2 diabetes (T2D), by reducing the various risk factors. The aim of this study was to concentrate glucoregulatory and anti-inflammatory peptides, from salmon by-products, by electrodialysis with ultrafiltration membrane (EDUF), and to identify peptides responsible for these bioactivities. Two EDUF configurations (1 and 2) were used to concentrate anionic and cationic peptides, respectively. After EDUF separation, two fractions demonstrated interesting properties: the initial fraction of the EDUF configuration 1 and the final fraction of the EDUF configuration 2 both showed biological activities to (1) increase glucose uptake in L6 muscle cells in insulin condition at 1 ng/mL (by 12% and 21%, respectively), (2) decrease hepatic glucose production in hepatic cells at 1 ng/mL in basal (17% and 16%, respectively), and insulin (25% and 34%, respectively) conditions, and (3) decrease LPS-induced inflammation in macrophages at 1 g/mL (45% and 30%, respectively). More impressive, the initial fraction of the EDUF configuration 1 (45% reduction) showed the same effect as the phenformin at 10 μM (40%), a drug used to treat T2D. Thirteen peptides were identified, chemically synthesized, and tested in-vitro for these three bioactivities. Thus, four new bioactive peptides were identified: IPVE increased glucose uptake by muscle cells, IVDI and IEGTL decreased hepatic glucose production (HGP) of insulin, whereas VAPEEHPTL decreased HGP under both basal condition and in the presence of insulin. To the best of our knowledge, this is the first time that (1) bioactive peptide fractions generated after separation by EDUF were demonstrated to be bioactive on three different criteria; all involved in the T2D, and (2) potential sequences involved in the improvement of glucose uptake and/or in the regulation of HGP were identified from a salmon protein hydrolysate. MDPI 2021-07-14 /pmc/articles/PMC8305187/ /pubmed/34357178 http://dx.doi.org/10.3390/membranes11070528 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Henaux, Loïc Pereira, Karina Danielle Thibodeau, Jacinthe Pilon, Geneviève Gill, Tom Marette, André Bazinet, Laurent Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides |
title | Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides |
title_full | Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides |
title_fullStr | Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides |
title_full_unstemmed | Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides |
title_short | Glucoregulatory and Anti-Inflammatory Activities of Peptide Fractions Separated by Electrodialysis with Ultrafiltration Membranes from Salmon Protein Hydrolysate and Identification of Four Novel Glucoregulatory Peptides |
title_sort | glucoregulatory and anti-inflammatory activities of peptide fractions separated by electrodialysis with ultrafiltration membranes from salmon protein hydrolysate and identification of four novel glucoregulatory peptides |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305187/ https://www.ncbi.nlm.nih.gov/pubmed/34357178 http://dx.doi.org/10.3390/membranes11070528 |
work_keys_str_mv | AT henauxloic glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides AT pereirakarinadanielle glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides AT thibodeaujacinthe glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides AT pilongenevieve glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides AT gilltom glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides AT maretteandre glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides AT bazinetlaurent glucoregulatoryandantiinflammatoryactivitiesofpeptidefractionsseparatedbyelectrodialysiswithultrafiltrationmembranesfromsalmonproteinhydrolysateandidentificationoffournovelglucoregulatorypeptides |